NKTR
Nektar Therapeutics
Price:  
1.64 
USD
Volume:  
1,135,045.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NKTR Fair Value

-391.86 %
Upside

As of 2024-05-26, the Fair Value of Nektar Therapeutics (NKTR) is -4.79 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.64 USD, the upside of Nektar Therapeutics is -391.86%.

Note: valuation result may not be accurate due to the company's negative EPS.

1.64 USD
Stock Price
-4.79 USD
Fair Price
FAIR VALUE CALCULATION

NKTR Fair Value

Peter Lynch's formula is:

NKTR Fair Value
= Earnings Growth Rate x TTM EPS
NKTR Fair Value
= 5.00 x -0.96
NKTR Fair Value
= -4.79

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income -440.70 -444.40 -523.80 -368.20 -276.06 -410.63
YoY growth -164.69% -0.84% -17.87% 29.71% 25.03% -25.73%

NKTR Fair Value - Key Data

Market Cap (mil) 301.14
P/E
Forward P/E
EPS -0.96
Avg earnings growth rate -25.73%
TTM earnings -175.78